Abstract
Introduction: The detection of myricetin as a major flavonoid content in some Kazakhstan bee products suggests that this flavonoid may be primarily responsible for the bioactive properties coming from bee products. In this study, therefore, it is worth investigating the necessity of planning in silico and in vitro analysis related to myricetin and bee products.Materials & Methods: The intersection of myricetin and oxidant targets was determined using jvenn tool. Subsequently, the intersection of oxidant targets and myricetin was transferred to the STRING database to construct a protein-protein interaction (PPI) network. Furthermore, GO and KEGG pathway enrichment analyses were performed on the selected core targets using the ShinyGO tool. On the other hand, the in vitro DPPH analysis and anti-inflammation tests were applied. Results: According to molecular docking scores, affinity values and low binding energies were obtained between myricetin and target proteins that are almost identical to those of trolox, the standard active ingredient. Bee-derived products showed notable antioxidant activity and moderate anti-inflammatory potential, whereas myricetin exhibited significantly stronger antioxidant and anti-inflammatory properties.Conclusion: The present in silico analyses suggest that myricetin may interact with multiple oxidative stress- and inflammation-related molecular targets. Network pharmacology, GO/KEGG enrichment, and molecular docking analyses collectively indicate the potential involvement of myricetin in reactive oxygen species (ROS) regulation and inflammatory signalling pathways. Supporting these computational findings, our experimental DPPH radical scavenging and anti-inflammatory assay results demonstrated that myricetin exhibited strong antioxidant and notable anti-inflammatory activities compared with bee-derived product extracts.